Works about DRUG labeling

Results: 2596

Post‐marketing safety of Lantus and its interchangeable biosimilar Semglee in the United States: A disproportionality analysis using the FDA Adverse Event Reporting System (FAERS) database.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4480, doi. 10.1111/dom.16491

By:

Ezeja, Lotanna;
Qian, Jingjing

Publication type:

Article

Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review Open Access.

Published in:

JNCI Cancer Spectrum, 2025, v. 9, n. 3, p. 1, doi. 10.1093/jncics/pkaf036

By:

King, Amanda L;
Vasilj, Tamara;
Cooper, Diane;
Vera, Elizabeth;
Berhanu, Sefanit;
Johnson, Morgan;
Locke, Ciara;
Mciver, Bennett;
Basch, Ethan;
Cappelleri, Joseph C;
Dueck, Amylou;
Gilbert, Mark R;
Jones, Lee;
Li, Yuelin;
Minasian, Lori M;
Reeve, Bryce B;
Armstrong, Terri S;
Mendoza, Tito

Publication type:

Article

Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine.

Published in:

Journal of Personalized Medicine, 2025, v. 15, n. 6, p. 245, doi. 10.3390/jpm15060245

By:

Díaz-Villamarín, Xando;
Martínez-Pérez, María;
Nieto-Sánchez, María Teresa;
Fernández-Varón, Emilio;
Torres-García, Alicia;
Blancas, Isabel;
Cabeza-Barrera, José;
Morón, Rocío

Publication type:

Article

Reply to Miller et al. Comment on "Hermeling et al. Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions. Pharmaceutics 2022, 14 , 2145".

Published in:

2025

By:

Hermeling, Malin;
Nueboldt, Christoph;
Heumann, Roman;
Hoheisel, Werner;
Breitkreutz, Joerg

Publication type:

Letter to the Editor

Opioid overdoses following use of cocaine and methamphetamine in New South Wales, and the public health responses.

Published in:

Emergency Medicine Australasia, 2025, v. 37, n. 2, p. 1, doi. 10.1111/1742-6723.70038

By:

Chisholm, Peter;
Brown, Jared;
Jiranantakan, Thanjira;
Harrod, Mary Ellen;
McDonald, Catherine;
Cullinan, Una;
Roberts, Darren M

Publication type:

Article

De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing.

Published in:

Emergency Medicine Australasia, 2017, v. 29, n. 5, p. 509, doi. 10.1111/1742-6723.12774

By:

Marwood, Joseph;
Aguirrebarrena, Gonzalo;
Kerr, Stephen;
Welch, Susan A;
Rimmer, Janet

Publication type:

Article

改良 365胰岛素有效期速查和推算转盘的设计与应用.

Published in:

Chinese Nursing Research, 2021, v. 35, n. 20, p. 3756, doi. 10.12102/j.issn.1009-6493.2021.20.042

By:

刘欢欢;
叶艳;
符一兰;
曾小翠;
梁彩雅;
金威;
刘海蔚

Publication type:

Article

Use and reimbursement of off-label drugs in pediatric anesthesia: the Italian experience.

Published in:

Pediatric Anesthesia, 2014, v. 24, n. 6, p. 625, doi. 10.1111/pan.12403

By:

Salvo, Ida;
Landoni, Giovanni;
Mucchetti, Marta;
Cabrini, Luca;
Pani, Luca;
Morton, Neil

Publication type:

Article

Rating-Scale Labeling in Online Surveys: An Experimental Comparison of Verbal and Numeric Rating Scales with Respect to Measurement Quality and Respondents' Cognitive Processes.

Published in:

Sociological Methods & Research, 2020, v. 49, n. 1, p. 79, doi. 10.1177/0049124117729694

By:

Menold, Natalja

Publication type:

Article

Study quality stymies conclusions about risks of third‐generation antipsychotics.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 6, p. 7, doi. 10.1002/pu.31167
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 9, doi. 10.1002/pu.31151
Publication type:: Article

Study finds comparatively few long‐term and high‐dose users of benzodiazepines.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 1, doi. 10.1002/pu.31106
Publication type:: Article

Approval.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 8, doi. 10.1002/pu.31041
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2022, v. 33, n. 2, p. 9, doi. 10.1002/pu.30836
Publication type:: Article

Approvals.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 10, p. 8, doi. 10.1002/pu.30789
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 11, p. 9, doi. 10.1002/pu.30649
Publication type:: Article

Boxed warning on antipsychotics may have caused harms in elderly.

Published in:: Brown University Psychopharmacology Update, 2020, v. 31, n. 8, p. 7, doi. 10.1002/pu.30608
Publication type:: Article

Warnings.

Published in:: Brown University Psychopharmacology Update, 2019, v. 30, n. 8, p. 8, doi. 10.1002/pu.30466
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2018, v. 29, n. 5, p. 9, doi. 10.1002/pu.30325
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2018, v. 29, n. 3, p. 9, doi. 10.1002/pu.30308
Publication type:: Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2018, v. 29, p. 1, doi. 10.1002/pu.30380
Publication type:: Article

YOUR MEDICATION INFORMATION.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, p. 1, doi. 10.1002/pu.30247
Publication type:: Article

Regulatory actions.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 2, p. 8, doi. 10.1002/pu.30209
Publication type:: Article

Findings on suicide and hypnotics signal need for further study.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 1, p. 3, doi. 10.1002/pu.30198
Publication type:: Article

Regulatory actions.

Published in:: Brown University Psychopharmacology Update, 2017, v. 28, n. 1, p. 8, doi. 10.1002/pu.30201
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2016, v. 27, n. 9, p. 8, doi. 10.1002/pu.30172
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2016, v. 27, n. 8, p. 8, doi. 10.1002/pu.30164
Publication type:: Article

Labeling.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, n. 6, p. 8, doi. 10.1002/pu.30055
Publication type:: Article

Modafinil Provigil.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, p. 1
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 8, doi. 10.1002/pu.30031
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 8, doi. 10.1002/pu.30023
Publication type:: Article

Pathological gambling, other disorders linked with dopamine agonists.

Published in:: Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 4, doi. 10.1002/pu.30021
Publication type:: Article

Analysis: Rise in youth suicide attempts followed FDA’s antidepressant warnings.

Published in:: Brown University Psychopharmacology Update, 2014, v. 25, n. 10, p. 1
Publication type:: Article

Analysis of varenicline studies finds no link with neuropsychiatric issues.

Published in:: Brown University Psychopharmacology Update, 2014, v. 25, n. 1, p. 1
Publication type:: Article

Rejection of Probuphine by FDA: Adequate dosing a key concern.

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, n. 7, p. 1
Publication type:: Article

Labeling revision for Wellbutrin.

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, n. 5, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 8, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 6, p. 8
Publication type:: Article

New approvals.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 5, p. 8
Publication type:: Article

FDA comments on Gibbons et al. (2012).

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 5, p. 5
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 4, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 3, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 8
Publication type:: Article

Increased risks of suicidal behavior and depression with varenicline in smoking cessation.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 7
Publication type:: Article

Commentary on Cooper et al.

Published in:

2012

By:

Kratochvil, Christopher J.

Publication type:

Opinion

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2012, v. 23, n. 1, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2011, v. 22, n. 12, p. 8
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2011, v. 22, n. 11, p. 8
Publication type:: Article

Pregabalin (generic) LYRICA (BRAND).

Published in:: Brown University Psychopharmacology Update, 2011, v. 22, p. 1
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2011, v. 22, n. 10, p. 8
Publication type:: Article